Live news related to ABIVAX stock (FR0012333284): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
French biotech company Abivax saw its shares soar by 27.07% Monday morning, crossing the threshold of 125.80 euros, while the CAC 40 index fell by 0.5…
Biotechnology company Abivax has outlined its outlook for 2026, focusing on the anticipated results of its phase 3 ABTECT-UC maintenance trial evaluat…
Biotechnology company Abivax has outlined its priorities for 2026, focusing on completing its Phase 3 maintenance trial for obefazimod in treating ulc…
ABIVAX stock closed at €115.00 on Friday, marking a 5.74% decline for the week of December 24 to January 2. This trend contrasts with the positive per…
The French biotech company Abivax recorded a 4.59% increase this Monday, December 29th, at mid-day, bringing its share price to 127.60 euros from 122.…
The French biotech company ended the trading session on Monday, December 29, with a marginal increase of 0.3%, settling at 122.40 euros, following a s…
ABIVAX stock closed on Friday at €122.00, marking a weekly increase of 22%. This rise is part of an exceptional annual performance of 1630%. While the…
The French biotech closed the session on December 22, 2025, at 115.40 euros, up sharply by 15.4% from the previous day. This increase occurred in the …
The French biotechnology company starts the session with a significant increase. The stock is up 9.4%, moving from 100 € the previous day to 109.40 € …
